Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
SSDXA-14 is a Phase 2 (feasibility/pilot) double-blind, placebo-controlled, crossover study
to evaluate the efficacy and safety of sacrosidase and placebo in 25 subjects objectively
diagnosed with fructan intolerance.